Jan Nilsson was appointed CEO of CombiGene October 1, 2016. Jan has a long and wide experience from both major pharmaceutical companies and biotech companies. Jan has been active in several areas of the pharmaceutical industry, from both drug development to sales and marketing of established international brands. Jan also has long experience of leadership and has served as CEO in both public and private companies.
Drug Development